Home › Trial NCT02227901
Tipifarnib, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
- Trial IDNCT02227901
- StatusCompleted
- PhasePhase 1
- Study typeInterventional
- SponsorNational Cancer Institute (NCI)
- Enrollment19
- Start date2002-09
- ConditionsAdult Giant Cell Glioblastoma · Adult Glioblastoma · Adult Gliosarcoma
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.